Success Stories

Discover how TRANSCAN-funded research projects produce visible results and contribute to our joint effort against cancer.

12.12.22

An interview with ECR, Dr. Pinar Pir

An interview with young Principal Investigator Dr. Pinar Pir, partner in the iParaCyts project funded under TRANSCAN-3 JTC 2021.

12.12.22

Meet Dr. Sheng-Fang Su, an early-career researcher involved in the BeFIT project.

23.12.21

TH4RESPONS investigated molecular and proteomic heterogeneity in triple-negative breast cancer and high-grade serous ovarian carcinoma.

23.12.21

ONTHETRRAC uncovered clinically relevant aspects of tumor heterogeneity in childhood neuroblastoma.